Advertisement

Topics

Harris Corporation to Announce Fourth Quarter Results on Tuesday, July 31, 2018

16:14 EDT 12 Jul 2018 | Businesswire

Harris Corporation

Harris Corporation (NYSE:HRS) will host a conference call on Tuesday, July 31, 2018, at 8:30 a.m. Eastern Time (ET) to discuss its fourth quarter fiscal year 2018 financial results. The company will issue a press release reporting its fourth quarter results at approximately 6:30 a.m. ET.

The dial-in numbers for the teleconference are (U.S.) 877-407-6184 and (International) 201-389-0877, and participants will be directed to an operator. Please allow at least 10 minutes before the scheduled start time to connect to the teleconference. Participants are encouraged to listen via webcast, and view management’s supporting slide presentation, which will be broadcast live at www.harris.com/investors/financial-reports. A recording of the call will be available on the Harris website, beginning at approximately 12 p.m. ET on July 31.

About Harris Corporation

Harris Corporation is a leading technology innovator, solving customers’ toughest mission-critical challenges by providing solutions that connect, inform and protect. Harris supports government and commercial customers in more than 100 countries and has approximately $6 billion in annual revenue. The company is organized into three business segments: Communication Systems, Electronic Systems and Space and Intelligence Systems. Learn more at harris.com.

Harris Corporation
Anurag Maheshwari, 321-727-9383
Investor Relations
anurag.maheshwari@harris.com
or
Jim Burke, 321-727-9131
jim.burke@harris.com

NEXT ARTICLE

More From BioPortfolio on "Harris Corporation to Announce Fourth Quarter Results on Tuesday, July 31, 2018"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...